<DOC>
	<DOCNO>NCT00914459</DOCNO>
	<brief_summary>The study investigate pharmacokinetics , safety efficacy patient less 12 year age severe hemophilia A previously treat Factor VIII product ( include blood product ) .</brief_summary>
	<brief_title>Study Evaluating Safety And Efficacy Of Moroctocog Alfa ( AF-CC ) In Previously Treated Hemophilia A Patients</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Male subject le 12 year age document history severe hemophilia A ( FVIII : C le 1 % ) . Subjects less 6 year age must least 50 Exposure Days ( EDs ) prior FVIII product ( include blood product ) . Subjects equal great 6 year age must great 150 EDs prior FVIII product ( include blood product ) . For laboratory assessment , measure Bethesda inhibitor titer equal great 0.6 BU , regardless laboratory normal range , Bethesda inhibitor titer great ULN test laboratory time screen . Any bleed disorder addition hemophilia A . Treatment investigational drug device within 30 day time sign parental informed consent/assent form . Major surgery plan occur course study . Regular ( e.g. , daily ; every day ) use agent medication know influence platelet function aspirin certain nonsteroidal antiinflammatory drug ( NSAIDS ) . Regular , concomitant therapy immunomodulating drug ( e.g. , intravenous immunoglobulin [ IVIG ] , routine systemic corticosteroid ) , currently receive immune tolerance induction ( ITI ) inhibitor treatment . The subject receiving treatment HIV hepatitis infection ( unless subject stable antiviral regimen [ i.e. , consistent treatment regimen least 3 month parental informed consent/assent form sign ] ) . Platelet count less 100,000/ÂµL . Prothrombin time ( PT ) equal great 1.25 x ULN , international normalize ratio ( INR ) equal great 1.5 . Known hypersensitivity hamster protein .</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>hemophilia A</keyword>
</DOC>